In this aggressive mouse model of
breast cancer, loss of MMP-8 accelerated
tumor onset even further, such that 90% of MMTV-PyMT; Mmp8-null female mice were
tumor-bearing at the time of weaning. Throughout the 14 weeks of the model,
tumor burden increased in homozygous Mmp8-null mice compared to Mmp8-wild-type and -heterozygote animals. Likewise, lung
metastasis dramatically increased in the MMTV-PyMT; Mmp8-null mice. Immunohistochemistry revealed that
tumors in wild-type, Mmp8-heterozygotes and -null animals had similar vascular density at 8 weeks, but at 10 weeks Mmp8-wild-type
tumors had a lower vascularity than their heterozygote and null counterparts. No differences in macrophage infiltration were apparent throughout primary
tumor development, though at 10 weeks a drop in neutrophil infiltrates was observed in Mmp8-wild-type
tumors. Using quantitative real-time RT-PCR, we tracked the expression of the entire
Mmp and Timp gene families, observing a significant decrease in Mmp3 expression in Mmp8-null
tumors compared to wild-type and heterozygotes throughout the time course of the model, which was confirmed at the
protein level.
CONCLUSIONS: These findings provide novel insight into the suppressive action of MMP-8 on mammary
tumorigenesis and
metastasis, and indicate that the loss of MMP-8 likely has pleiotropic effects on innate immunity and angiogenesis that are reflected in changes in the
protease web.